World's Best Scientists 2026 revealed!
Chinese Clinical Oncology
H-index 13

Chinese Clinical Oncology

2304-3865

Published by: AME Publishing Company

https://cco.amegroups.com/

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 1996 44 47 12

Additional Metrics

Number of Best Scientists*: 67
Documents by Best Scientists*: 69
Top 100 Ranked Scientists*: 1
SCIMAGO H-index: 44
SCIMAGO SJR: 0.636
Impact Factor: 2.7

Overview

Top Research Topics at Chinese clinical oncology?

The aim of the journal is to expand the discussion of research in Internal medicine, Oncology, Chemotherapy, Surgery and Cancer. It focuses on Internal medicine research which is adjacent to topics in Gastroenterology. In addition to Oncology research, Chinese clinical oncology aims to explore topics under Immunohistochemistry, Cisplatin, Survival rate, Breast cancer and Colorectal cancer.

While Immunohistochemistry is the focus of it, it also provided insights into the studies of Cancer research, Pathological, Metastasis and Clinical significance. Cancer research research in Chinese clinical oncology involves the investigation of Apoptosis studies, all of which are linked to disciplines such as Molecular biology. The studies on Chemotherapy discussed can also contribute to research in the domains of Nausea, Vomiting, Adverse effect and Oxaliplatin.

In particular, the Surgery works presented emphasize discussions on Radiation therapy. The field of Radiology is the anchor for the Radiation therapy studies presented in the journal. Topics in Lung cancer explored in the journal were investigated in conjunction with research in Lung and Adenocarcinoma.

  • Internal medicine (47.44%)
  • Oncology (35.06%)
  • Chemotherapy (22.89%)

What are the most cited papers published in the journal?

  • Staging and response assessment in lymphomas: the new Lugano classification. (79 citations)
  • Biliary carcinomas: pathology and the role of DNA mismatch repair deficiency (79 citations)
  • Genetic and epigenetic landscape of nasopharyngeal carcinoma (58 citations)

Research areas of the most cited articles at Chinese clinical oncology:

The journal publications focus largely on the fields of Internal medicine, Oncology, Clinical trial, Cancer and Nasopharyngeal carcinoma. The most cited publications focus on Internal medicine but the discussions also offer insight into other areas such as Gastroenterology and Genome-wide association study. The studies on Oncology discussed at the published papers can also contribute to research in the domains of Neoadjuvant therapy, Regimen, Surgery, Chemotherapy and Research design.

What topics the last edition of the journal is best known for?

  • Cancer
  • Internal medicine
  • Surgery

The previous edition focused in particular on these issues:

The journal mainly tackles studies in Internal medicine, Oncology, Glioblastoma, Radiology and Hepatocellular carcinoma. Chinese clinical oncology concentrated on Internal medicine research, specifically Breast cancer, Radiation therapy, Cohort, Adjuvant and Platinum resistant. The Breast cancer research presented in Chinese clinical oncology explores the relationship between Clinical trial and the closely related topic of Study Characteristics.

The work on Oncology tackled in Chinese clinical oncology brings together disciplines like MEDLINE and Immunotherapy. The research on Hepatocellular carcinoma tackled can also make contributions to studies in the areas of Cancer, Liver transplantation, Transplantation and Hepatitis B. Some problems in Cancer that were presented in Chinese clinical oncology overlapped with concepts under Disease, Bioinformatics and Intensive care medicine.

The most cited articles from the last journal are:

  • Hepatocellular carcinoma, novel therapies on the horizon. (4 citations)
  • Systemic therapy for advanced hepatocellular carcinoma: targeted therapies. (3 citations)
  • Anti-angiogenic therapies in the management of glioblastoma. (3 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Chinese clinical oncology (based on the number of publications) are:

  • Pla Cancer (36 papers) absent at the last edition,
  • Wang Jie-ju (27 papers) absent at the last edition,
  • Qin Shu-ku (17 papers) absent at the last edition,
  • Liang Hou-ji (13 papers) absent at the last edition,
  • Ghassan K. Abou-Alfa (13 papers) published 1 paper at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Chinese clinical oncology (based on the number of publications) are:

  • Memorial Sloan Kettering Cancer Center (47 papers) published 1 paper at the last edition, 1 less than at the previous edition,
  • University of Texas MD Anderson Cancer Center (42 papers) published 5 papers at the last edition, 1 less than at the previous edition,
  • Nanjing Medical University (23 papers) absent at the last edition,
  • Mayo Clinic (20 papers) published 2 papers at the last edition the same number as at the previous edition,
  • Peking University (18 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 9.43% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 16.67% were posted by at least one author from the top 10 institutions publishing in the journal. Another 6.25% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 37.50% of all publications and 39.58% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Pathways in Chinese Clinical Oncology

For aspiring researchers and medical professionals interested in contributing to the field of Chinese clinical oncology, understanding the necessary educational requirements and the career pathways is essential. Traditionally, building a career in clinical oncology requires extensive education, including a medical degree, followed by specialized training in oncology. Notably, many professionals also pursue additional qualifications related to internal medicine and research methodology.

Furthermore, the field of oncology is highly interdisciplinary, often intersecting with areas like gastroenterology, chemotherapy, and radiology. Therefore, broad-based knowledge in these fields can be valuable. A related professional field that requires a comprehensive understanding of these intersections is that of the nurse practitioner, particularly those specializing in oncology and internal medicine.

For those interested in such a career pathway, understanding nurse practitioner education requirements in Indiana, as an example, can provide valuable insights. Such a career can offer a unique perspective on the clinical aspect of oncology while staying actively involved in patient care. Ultimately, a career in Chinese clinical oncology can be rewarding and impactful, though it certainly requires deep commitment and rigorous academic pursuit.

Top Publications

Related Online Degrees & Career Pathways

For those interested in expanding their career options in the medical field without pursuing a traditional medical degree, several related online programs offer valuable alternatives. Affordable options like the affordable mha online programs provide a strong foundation in healthcare management, perfect for leadership roles in hospitals and clinics.

For individuals seeking quicker entry into clinical support roles, fast track lpn courses offer accelerated paths to become Licensed Practical Nurses, which can be a stepping stone in healthcare careers.

Advanced nursing professionals may consider pursuing an online doctorate in nursing to deepen expertise and qualify for roles in research, education, or specialized clinical practice, all while balancing work and study commitments.

For those inclined towards administrative roles, training through the best online medical billing and coding schools can open doors to essential positions that support healthcare providers and ensure proper insurance reimbursement.

Each pathway offers unique benefits and challenges, so prospective students should carefully consider their career goals and time commitments when choosing the best fit.

Best Scientists Contributing to This Journal

Recently Published Articles